Atlas Trials

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Clinical trial NCT04854005 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04854005
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2021-05-20
Primary completion
2027-04-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.